Common Shares Outstanding: The number of class A shares currently held by investors.
Entrada Therapeutics, Inc. (TRDA) had Common Shares Outstanding of 38.03M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.95M |
|
$-43.10M |
|
-- |
|
$1.95M |
|
$48.80M |
|
$-46.85M |
|
$3.92M |
|
$-42.92M |
|
$-42.92M |
|
$-43.10M |
|
$-43.10M |
|
$-43.10M |
|
$-43.10M |
|
$-46.85M |
|
$-46.78M |
|
41.34M |
|
41.34M |
|
$-1.04 |
|
$-1.04 |
|
| Balance Sheet Financials | |
$369.15M |
|
$9.81M |
|
$79.64M |
|
$448.78M |
|
$19.80M |
|
-- |
|
$49.48M |
|
$69.28M |
|
$379.50M |
|
$379.50M |
|
$379.50M |
|
|
Common Shares Outstanding |
38.03M |
| Cash Flow Statement Financials | |
$-68.00M |
|
$38.58M |
|
$0.69M |
|
$105.16M |
|
$76.43M |
|
$-28.73M |
|
$10.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2402.51% |
|
-2402.51% |
|
-- |
|
-2201.28% |
|
-2210.41% |
|
$-69.42M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.65 |
|
54.46 |
|
-11.36% |
|
-11.36% |
|
-9.60% |
|
-11.36% |
|
$9.98 |
|
$-1.68 |
|
$-1.64 |
|